It is therefore possible that in conditions as encountered during sepsis where several molecular species of lipid A are present, the joint existence of the two TLR4:MD2 signaling pathways may allow incomplete forms of lipid A to contribute to inflammation through synergistic or antagonistic effects. The gene discussed is LY96; the disease is Sepsis.